NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email President Trump raised his new, global tariffs to 15%, one day after the Supreme Court struck down many of his punishing taxes. Willie James Inman reports on the impact on American businesses and whether there could be refunds issued.Read More